{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:06:50Z","timestamp":1793747210107,"version":"4.6.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.semradonc.2025.05.001","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T23:16:02Z","timestamp":1749770162000},"page":"385-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Debate 1: Radical Prostatectomy For the Right Patient With High-Risk Prostate Cancer"],"prefix":"10.1016","volume":"35","author":[{"given":"Vinaik M.","family":"Sundaresan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Leapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semradonc.2025.05.001_bib0001","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/S0022-5347(05)65531-0","article-title":"Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era","volume":"166","author":"D'Amico","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0002","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1097\/01.ju.0000158155.33890.e7","article-title":"The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy","volume":"173","author":"Cooperberg","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0003","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1097\/01.ju.0000091805.98960.13","article-title":"A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer","volume":"170","author":"Cagiannos","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0004","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.urolonc.2019.08.006","article-title":"Evaluation of MSKCC Preprostatectomy nomogram in men who undergo MRI-targeted prostate biopsy prior to radical prostatectomy","volume":"37","author":"Glaser","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0005","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Schaeffer","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0006","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1001\/jamaoncol.2020.4922","article-title":"Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate","volume":"6","author":"Dess","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0007","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00345-008-0250-7","article-title":"High-risk prostate cancer in the United States, 1990-2007","volume":"26","author":"Cooperberg","year":"2008","journal-title":"World J Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0008","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00345-018-2396-2","article-title":"Inverse stage migration patterns in North American patients undergoing local prostate cancer treatment: a contemporary population-based update in light of the 2012 USPSTF recommendations","volume":"37","author":"Leyh-Bannurah","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0009","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00345-024-05262-0","article-title":"Changing times: trends in risk classification, tumor upstaging, and positive surgical margins after radical prostatectomy - results from a contemporary National Cancer Database study","volume":"42","author":"Freitas","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0010","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0011","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.juro.2015.12.025","article-title":"Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer","volume":"195","author":"Maurer","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0012","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.eururo.2015.12.051","article-title":"(68)Ga-PSMA Positron Emission Tomography\/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer","volume":"70","author":"Herlemann","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0013","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.40591","article-title":"Long-Term Outcomes of Prostate-Specific Membrane Antigen-PET Imaging of Recurrent Prostate Cancer","volume":"7","author":"Kunst","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0014","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.euo.2023.02.005","article-title":"Decision Regret in Patients with Localised Prostate Cancer: A Systematic Review and Meta-analysis","volume":"6","author":"Fanshawe","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0015","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1002\/cncr.21822","article-title":"Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer","volume":"106","author":"Zeliadt","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0016","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.32900","article-title":"Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy","volume":"6","author":"Falagario","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0017","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/jnci\/djn255","article-title":"Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial","volume":"100","author":"Bill-Axelson","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0018","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1311593","article-title":"Radical prostatectomy or watchful waiting in early prostate cancer","volume":"370","author":"Bill-Axelson","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0019","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa1807801","article-title":"Radical Prostatectomy or Watchful Waiting in Prostate Cancer - 29-Year Follow-up","volume":"379","author":"Bill-Axelson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0020","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMc2406108","article-title":"Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer","volume":"391","author":"Holmberg","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0021","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa1615869","article-title":"Follow-up of Prostatectomy versus Observation for Early Prostate Cancer","volume":"377","author":"Wilt","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0022","first-page":"266","article-title":"The Prostate Cancer Intervention Versus Observation Trial (PIVOT) in Perspective","volume":"5","author":"Cheng","year":"2013","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0023","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/jnci\/djn259","article-title":"SPCG-4: a needed START to PIVOTal data to promote and protect evidence-based prostate cancer care","volume":"100","author":"Wilt","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0024","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.eururo.2023.09.024","article-title":"Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer","volume":"85","author":"Herlemann","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.eururo.2010.10.003","article-title":"A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006","volume":"59","author":"Abdollah","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0026","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eururo.2015.11.010","article-title":"Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis","volume":"70","author":"Wallis","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0027","doi-asserted-by":"crossref","first-page":"g1502","DOI":"10.1136\/bmj.g1502","article-title":"Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes","volume":"348","author":"Sooriakumaran","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0028","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.8006","article-title":"Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer","volume":"2","author":"Kishan","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0029","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.eururo.2019.10.008","article-title":"Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials","volume":"77","author":"Kishan","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1615\/CritRevOncog.2018025946","article-title":"Profiles of Radioresistance Mechanisms in Prostate Cancer","volume":"23","author":"Chaiswing","year":"2018","journal-title":"Crit Rev Oncog"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11195637","article-title":"Drivers of Radioresistance in Prostate Cancer","volume":"11","author":"King","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0032","article-title":"Gene signature predictor of dose-response to prostate radiation: Validation of PORTOS in phase III trials","volume":"43","author":"Zhao","year":"2025","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0033","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.eururo.2008.03.049","article-title":"Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysis","volume":"54","author":"Cohen","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0034","doi-asserted-by":"crossref","first-page":"981","DOI":"10.37349\/etat.2024.00259","article-title":"Risk factors for Gleason score upgrade from prostate biopsy to radical prostatectomy","volume":"5","author":"Smani","year":"2024","journal-title":"Explor Target Antitumor Ther"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0035","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.eururo.2012.01.050","article-title":"Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades","volume":"61","author":"Epstein","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0036","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/JU.0000000000002758","article-title":"Clinically Localized Prostate Cancer: AUA\/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0037","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.eururo.2020.11.040","article-title":"Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial","volume":"79","author":"Lestingi","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0038","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1002\/cncr.26169","article-title":"The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy","volume":"117","author":"Cooperberg","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0039","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jama.291.11.1325","article-title":"Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy","volume":"291","author":"Stephenson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijrobp.2005.01.020","article-title":"Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy","volume":"63","author":"Cheung","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0041","doi-asserted-by":"crossref","first-page":"8192","DOI":"10.1200\/JCO.2005.03.0007","article-title":"Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy","volume":"23","author":"Lee","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0042","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.urology.2004.12.013","article-title":"Prostate-specific antigen velocity accurately predicts response to salvage radiotherapy in men with biochemical relapse after radical prostatectomy","volume":"65","author":"Patel","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0043","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(20)31553-1","article-title":"Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial","volume":"396","author":"Parker","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0044","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S1470-2045(20)30454-X","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial","volume":"21","author":"Sargos","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.eururo.2015.07.029","article-title":"Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis","volume":"70","author":"de Rooij","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0046","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/jamaoncol.2021.3771","article-title":"Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial","volume":"7","author":"Hope","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0047","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2024.10.006","article-title":"Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended Dissection","volume":"87","author":"Touijer","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0048","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.juro.2006.04.048","article-title":"Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading","volume":"176","author":"Donohue","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0049","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/jama.294.4.433","article-title":"Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy","volume":"294","author":"Freedland","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.eururo.2013.03.053","article-title":"Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy","volume":"65","author":"Touijer","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0051","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.juro.2014.11.017","article-title":"Ultrasensitive prostate specific antigen after prostatectomy reliably identifies patients requiring postoperative radiotherapy","volume":"193","author":"Kang","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0052","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S1470-2045(20)30456-3","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03\/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial","volume":"21","author":"Kneebone","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0053","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1002\/cam4.3482","article-title":"Trends in prostatectomy utilization: Increasing upfront prostatectomy and postprostatectomy radiotherapy for high-risk prostate cancer","volume":"9","author":"Kaps","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0054","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1200\/JCO.21.02800","article-title":"Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death","volume":"40","author":"Tilki","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0055","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.ijrobp.2022.07.398","article-title":"Prognostic and Predictive Performance of a 24-Gene Post-Operative Radiation Therapy Outcomes Score (PORTOS) in a Phase 3 Randomized Trial of Dose-Intensified Salvage Radiotherapy after Radical Prostatectomy (SAKK 09\/10)","volume":"114","author":"Pra","year":"2022","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0056","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.ju.0000150627.68410.4d","article-title":"Current status of local salvage therapies following radiation failure for prostate cancer","volume":"173","author":"Touma","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0057","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.euros.2023.03.017","article-title":"Incidence of Rectal Injury After Radical Prostatectomy: A Systematic Review and Meta-analysis","volume":"52","author":"Romito","year":"2023","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0058","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.euf.2023.01.013","article-title":"Salvage Radical Prostatectomy for Recurrent Prostate Cancer After Primary Nonsurgical Treatment: An Updated Systematic Review","volume":"9","author":"Marra","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0059","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","article-title":"A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER)","volume":"80","author":"Valle","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0060","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijrobp.2017.02.004","article-title":"Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202","volume":"98","author":"Lawton","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0061","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1470-2045(18)30757-5","volume":"20","author":"Denham","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0062","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJMoa2303974","article-title":"Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer","volume":"389","author":"Freedland","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0063","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","volume":"67","author":"Nguyen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0064","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(24)00549-X","article-title":"Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial","volume":"403","author":"Parker","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0065","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/jama.2023.26491","article-title":"Functional Outcomes After Localized Prostate Cancer Treatment","volume":"331","author":"Al Hussein Al Awamlh","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0066","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0067","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5489\/cuaj.1764","article-title":"Long-term complications in men who have early or late radiotherapy after radical prostatectomy","volume":"8","author":"Sowerby","year":"2014","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0068","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2340\/sju.v58.7318","article-title":"Salvage radiotherapy after radical prostatectomy: functional outcomes in the LAPPRO trial after 8-year follow-up","volume":"58","author":"Carlsson","year":"2023","journal-title":"Scand J Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0069","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.6359","article-title":"Evaluation of Patient- and Surgeon-Specific Variations in Patient-Reported Urinary Outcomes 3 Months After Radical Prostatectomy From a Statewide Improvement Collaborative","volume":"156","author":"Auffenberg","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0070","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.eururo.2012.05.046","article-title":"Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy","volume":"62","author":"Ficarra","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0071","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2012.05.045","article-title":"Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy","volume":"62","author":"Ficarra","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0072","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.eururo.2020.09.044","article-title":"Hood Technique for Robotic Radical Prostatectomy-Preserving Periurethral Anatomical Structures in the Space of Retzius and Sparing the Pouch of Douglas, Enabling Early Return of Continence Without Compromising Surgical Margin Rates","volume":"80","author":"Wagaskar","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0073","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.eururo.2020.05.010","volume":"79","author":"Egan","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0074","article-title":"Long-Term Oncological Outcomes after Nerve-Sparing Robot-Assisted Radical Prostatectomy for High-Risk Localized Prostate Cancer: A Single-Center, Two-Arm Prospective Study","volume":"14","author":"Spirito","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11701-016-0627-3","article-title":"Safety of selective nerve sparing in high risk prostate cancer during robot-assisted radical prostatectomy","volume":"11","author":"Kumar","year":"2017","journal-title":"J Robot Surg"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0076","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.juro.2008.07.038","article-title":"Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study","volume":"180","author":"Nieder","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0077","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ijrobp.2009.02.011","article-title":"The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients","volume":"76","author":"Bhojani","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0078","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.juro.2016.08.101","article-title":"Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment","volume":"197","author":"Chang","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.semradonc.2025.05.001_bib0079","doi-asserted-by":"crossref","first-page":"E250","DOI":"10.1111\/bju.12169","article-title":"Primary treatment of the prostate improves local palliation in men who ultimately develop castrate-resistant prostate cancer","volume":"112","author":"Won","year":"2013","journal-title":"BJU Int"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429625000463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429625000463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T19:06:21Z","timestamp":1750791981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429625000463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1053429625000463"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2025.05.001","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Debate 1: Radical Prostatectomy For the Right Patient With High-Risk Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semradonc.2025.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}